February 21, 2017 / 2:16 PM / 6 months ago

BRIEF-Eyegate Pharmaceuticals says under license agreement, Valeant to make upfront payment of $4.0 mln - SEC filing

Feb 21 (Reuters) - Eyegate Pharmaceuticals Inc

* Eyegate Pharmaceuticals Inc - under license agreement, Valeant will pay company an upfront payment of $4.0 million - SEC filing

* Eyegate Pharmaceuticals Inc - under agreement, company is eligible to receive milestone payments totaling up to approximately $99.0 million Source text: (bit.ly/2lCbsEt) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below